ALEXANDRIA
LIVE

Serial Number

98220978

Owner

Atropos Health, Inc.

Attorney

Thomas Y. Yee

First Use Date

Dec 14, 2023

Filing Date

Oct 12, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ALEXANDRIA Trademark

Serial Number: 98220978 • Registration: 7860519

ALEXANDRIA is a trademark filed by Atropos Health, Inc. on October 12, 2023. The trademark is classified under Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Atropos Health, Inc. (20 trademarks)

169 Madison Avenue, Unit 2242
New York, NY 10016

Entity Type: 03

Trademark Details

Filing Date

October 12, 2023

Registration Date

July 8, 2025

First Use Anywhere

December 14, 2023

First Use in Commerce

December 14, 2023

Published for Opposition

July 30, 2024

Goods & Services

Providing access to an electronic exchange of health data and data analyses across an integrated nationwide clinical research network; transmission of health and medical record and life science report and article database information and analyses of health and medical record and life science report and articles database information via telecommunications networks; electronic exchange of health data and life science report and articles insights via telecommunication networks for analyses of health data from clinicians, health systems, academic medical centers, life sciences companies, and others; electronic transmission of health data; all of the foregoing services may also be provided by means of artificial intelligence

Business consulting and data management in the field of clinical trials, namely, providing information management services by means of data compilation; collection, reporting, and analysis of healthcare records, clinical records, and life science report and article-related data for business purposes; services consisting of the registration, collection, transcription, compilation, clarification, enablement, enhancement, management, mapping, and systemization of written communications and data; all of the foregoing services may also be provided by means of artificial intelligence

Providing medical information to healthcare providers and healthcare professionals, and life sciences companies to help them make informed decisions for patient diagnosis and treatment and clinical trial design, emulation, strategy, and prioritization; providing health data analysis to healthcare providers and healthcare professionals in the medical and patient-care industry to help them to assess clinical data for the purpose of patient diagnosis and treatment and improving quality of care in the medical and healthcare industry; providing information and data related to patient data, namely, demographics, diagnoses, procedures, medications, laboratory values, clinical notes, mortality, and length of stay information for patients to inform clinical care decisions and research and to inform life science company corporate strategy, research and development, and marketing and brand planning; providing on-line medical and clinical record and life science articles and reports analysis services designed to provide healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; providing on-line medical and clinical record and life science articles and reports analysis services designed to provide medical providers with custom tailored information about the outcomes for patients with similar symptoms and evidence needed for patient care decisions; compiling, clarifying, enabling, enhancing, managing, mapping, and analyzing medical and clinical data and life science articles and reports for medical treatment purposes; all of the foregoing services may also be provided by means of artificial intelligence

Providing medical, health, and scientific research information, research data, and research services to assist healthcare providers, healthcare professionals, and life sciences companies in making informed decisions for patient diagnosis and treatment and clinical trial design, emulation, strategy, and prioritization; medical research services, namely, collecting, storing, indexing, analyzing, updating, managing, sharing, and reporting real world data to create actionable insights for use by healthcare providers, healthcare professionals, and life sciences companies; providing medical and scientific research information in the field of clinical trials and life sciences; compiling data for research purposes in the field of medical science and medical consultancy and life sciences; software as a service (SAAS) services featuring software for providing diagnosis and treatments recommendations for physicians and researchers; software as a service (SAAS) services featuring software for collecting, storing, indexing, analyzing, updating, managing, sharing, clarifying, enabling, enhancing, managing, mapping, and reporting clinical trial, data, electronic health records, claims data, life science articles and report, and medical research data to evaluate and recommend medical diagnoses and treatments; software as a service (SAAS) services featuring software for searching, organizing and managing data, namely, demographics, diagnoses, procedures, medications, laboratory values, clinical notes, mortality, and length of stay information for patients to inform clinical care decisions and research; software as a service (SAAS) services featuring software for providing healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; software as a service (SAAS) services featuring software for compiling, clarifying, enabling, enhancing, managing, mapping, and analyzing medical records and health data and life science articles and reports; software as a service (SAAS) services featuring software using a natural language or large language model, artificial intelligence, and machine learning for compiling, clarifying, enabling, enhancing, managing, mapping, and analyzing medical records and health data and life science articles and reports; software as a service (SAAS) services featuring chatbot software using a natural language or large language model or artificial intelligence for compiling, clarifying, enabling, enhancing, managing, mapping, and analyzing medical records and health data and life science articles and reports and providing tailored reports regarding the data to physicians and researchers; compiling data for research purposes in the field of medical science and medical consultancy; software as a service (SAAS) services featuring software for generating and accessing library of reports derived from data sources

Filing History

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 16, 2025 SUNA
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 8, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 8, 2025 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 17, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 16, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 16, 2025 AITU
USE AMENDMENT FILED
Mar 18, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 18, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 18, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 17, 2025 EX1G
SOU EXTENSION 1 FILED
Mar 17, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 17, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 24, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 24, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 24, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 24, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 24, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 11, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 11, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 11, 2024 CNRT
ASSIGNED TO EXAMINER
May 30, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2023 NWOS
NEW APPLICATION ENTERED
Oct 16, 2023 NWAP